| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8945325 | European Journal of Surgical Oncology (EJSO) | 2018 | 6 Pages |
Abstract
The EORTC-STBSG response score is applicable for determining the histopathological response to neoadjuvant ESTS treatment. However, this response does not seem to predict LRFS nor OS in locally advanced ESTS.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marc G. Stevenson, Harald J. Hoekstra, Wangzhao Song, Albert J.H. Suurmeijer, Lukas B. Been,